Please use this identifier to cite or link to this item: https://doi.org/10.1007/s00281-014-0436-6
Title: The immunopathology of ANCA-associated vasculitis
Authors: McKinney, E.F
Willcocks, L.C
Broecker, V
Smith, K.G.C 
Keywords: complement component C5a
cyclophosphamide
enzyme antibody
immunosuppressive agent
lysosome associated membrane protein 2
myeloblastin
myeloperoxidase antibody
neutrophil cytoplasmic antibody
rituximab
T lymphocyte receptor
unclassified drug
neutrophil cytoplasmic antibody
ANCA associated vasculitis
antibody titer
antigen antibody reaction
CD4+ T lymphocyte
CD8+ T lymphocyte
clinical feature
complement system
copy number variation
disease classification
genetic association
genetic risk
histopathology
human
immunopathology
immunosuppressive treatment
in vivo study
lymphocyte function
lymphocytic infiltration
major histocompatibility complex
nonhuman
prevalence
priority journal
relapse
review
single nucleotide polymorphism
treatment outcome
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
classification
immunology
pathology
syndrome
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Antibodies, Antineutrophil Cytoplasmic
Humans
Syndrome
Issue Date: 2014
Citation: McKinney, E.F, Willcocks, L.C, Broecker, V, Smith, K.G.C (2014). The immunopathology of ANCA-associated vasculitis. Seminars in Immunopathology 36 (4) : 461-478. ScholarBank@NUS Repository. https://doi.org/10.1007/s00281-014-0436-6
Rights: Attribution 4.0 International
Abstract: The small-vessel vasculitides are a group of disorders characterised by variable patterns of small blood vessel inflammation producing a markedly heterogeneous clinical phenotype. While any vessel in any organ may be involved, distinct but often overlapping sets of clinical features have allowed the description of three subtypes associated with the presence of circulating anti-neutrophil cytoplasmic antibodies (ANCA), namely granulomatosis with polyangiitis (GPA, formerly known as Wegener's Granulomatosis), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (eGPA, formerly known as Churg-Strauss syndrome). Together, these conditions are called the ANCA-associated vasculitidies (AAV). Both formal nomenclature and classification criteria for the syndromes have changed repeatedly since their description over 100 years ago and may conceivably do so again following recent reports showing distinct genetic associations of patients with detectable ANCA of distinct specificities. ANCA are not only useful in classifying the syndromes but substantial evidence implicates them in driving disease pathogenesis although the mechanism by which they develop and tolerance is broken remains controversial. Advances in our understanding of the pathogenesis of the syndromes have been accompanied by some progress in treatment, although much remains to be done to improve the chronic morbidity associated with the immunosuppression required for disease control. © 2014 The Author(s).
Source Title: Seminars in Immunopathology
URI: https://scholarbank.nus.edu.sg/handle/10635/181779
ISSN: 18632297
DOI: 10.1007/s00281-014-0436-6
Rights: Attribution 4.0 International
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1007_s00281-014-0436-6.pdf1.13 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons